Furthermore, SGLT2 inhibitors could attenuated the growth of cervical carcinoma [12], liver cancer [13] and breast cancer [14] by inhibiting glucose uptake in cancer cells. The gene discussed is SLC5A2; the disease is breast carcinoma.